Unicycive Therapeutics Inc.

UNCY | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.77

-$0.03 (-0.63%)

At close: Sep 21, 2026, 4:00 PM ET

$4.77

$0 (0.00%)

Pre-market: Sep 22, 2026, 8:44 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $127.36M

Enterprise Value $66.61M

Beta 1.78

Average Volume 1.26M

Shares Outstanding (Diluted) 26.92M

Shares Change YoY 118.8%

Institutional Ownership 41.43%

Exchange NASDAQ

ISIN US90466Y2028

Price Performance

Price Change 1M -15.4%

Price Change 3M -40.5%

Price Change 6M -28.3%

Price Change YTD -17.8%

Price Change 1Y 20.4%

Price Change 3Y -26.8%

Price Change 5Y -83.4%

1M CAGR (ann.) -5.9%

1Y CAGR (ann.) 16.6%

5Y CAGR (ann.) -30.3%

All-Time CAGR -36.4%

Valuation

PE Ratio -2.86

Forward PE 2.52

PEG Ratio -0.03

Forward PEG 0.01

PS Ratio N/A

Forward PS 0.80

PB Ratio 2.39

P/FCF Ratio -4.57

P/Adj. FCF Ratio -3.95

P/OCF Ratio -4.63

EV/Sales N/A

EV/EBIT -1.89

EV/EBITDA -1.93

EV/FCF -2.39

Earnings Yield -35.0%

FCF Yield -21.9%

Adj. FCF Yield -25.3%

Financial Health

Net Cash $61.43M

Total Debt $671K

Cash & Short-Term Investments $61.43M

Total Assets $72.03M

Current Ratio 3.81

Quick Ratio 3.81

Debt / Equity Ratio 0.01

Debt / EBITDA -0.02

Debt / FCF -0.02

OCF / Debt -41.49

Interest Coverage -789.12

Altman Z-Score 0.57

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -15.8%

Returns

Return on Assets -48.9%

Return on Equity -88.8%

Return on Invested Capital -61.4%

Return on Capital Employed -62.1%

Return on Tangible Assets -48.9%

Historical Growth (CAGR)

Revenue CAGR 3Y -150.0%

Revenue CAGR 5Y -50.0%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 52.2%

EPS CAGR 5Y 39.0%

EPS CAGR 10Y N/A

FCF CAGR 3Y -11.2%

FCF CAGR 5Y -21.3%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 8

EPS Growth Next 3Y 152.1%

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$0.32

EPS Growth Est (next Q) -3.0%

Revenue Est (next Q) $902.78K

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $22

Price Target Upside 361.2%

Cash Flow

Operating Cash Flow $-27.84M

Free Cash Flow $-27.85M

Adj. Free Cash Flow $-32.26M

FCF Per Share -$1.03

OCF Per Share -$1.03

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-211K

Operating Income $-33.14M

EBITDA $-34.52M

Net Income $-35.22M

EPS (Diluted) -$1.67

Revenue / Employee N/A

Profit / Employee $-1.68M

Employees 21